Roles of Inflammasomes in Inflammatory Kidney Diseases

被引:41
|
作者
Fan, Jinjin [1 ]
Xie, Kaifeng [2 ]
Wang, Liqin [3 ]
Zheng, Nuoyan [4 ]
Yu, Xueqing [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510000, Guangdong, Peoples R China
[2] Guangdong Med Univ, Zhanjiang 524001, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510000, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Translat Med Ctr, Guangzhou 510000, Guangdong, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; INHIBITING NLRP3 INFLAMMASOME; ATTENUATES MURINE LUPUS; INNATE IMMUNE DETECTION; SMOOTH-MUSCLE-CELLS; RENAL INFLAMMATION; MECHANISTIC INSIGHTS; RHEUMATOID-ARTHRITIS; DIABETIC-NEPHROPATHY; RECEPTOR ANTAGONIST;
D O I
10.1155/2019/2923072
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune system has a central role in eliminating detrimental factors, by frequently launching inflammatory responses towards pathogen infection and inner danger signal outbreak. Acute and chronic inflammatory responses are critical determinants for consequences of kidney diseases, in which inflammasomes were inevitably involved. Inflammasomes are closely linked to many kidney diseases such as acute kidney injury and chronic kidney diseases. Inflammasomes are macromolecules consisting of multiple proteins, and their formation initiates the cleavage of procaspase-1, resulting in the activation of gasdermin D as well as the maturation and release of interleukin-1 beta and IL-18, leading to pyroptosis. Here, we discuss the mechanism in which inflammasomes occur, as well as their roles in inflammatory kidney diseases, in order to shed light for discovering new therapeutical targets for the prevention and treatment of inflammatory kidney diseases and consequent end-stage renal disease.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Mitophagy, Inflammasomes and Their Interaction in Kidney Diseases: A Comprehensive Review of Experimental Studies
    Wang, Yulin
    Song, Dongxu
    Tang, Lin
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 1457 - 1469
  • [22] Non-Coding RNAs: Master Regulators of Inflammasomes in Inflammatory Diseases
    Wang, Wei
    Yang, Ni
    Yang, Yu-Hang
    Wen, Ri
    Liu, Chun-Feng
    Zhang, Tie-Ning
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 5023 - 5050
  • [23] The Inflammasomes in Kidney Disease
    Anders, Hans-Joachim
    Muruve, Daniel A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (06): : 1007 - 1018
  • [24] Inflammasomes in inflammatory pathology
    Lamkanfi, M.
    TOXICOLOGY LETTERS, 2019, 314 : S20 - S20
  • [25] Inflammasomes in liver diseases
    Szabo, Gyongyi
    Csak, Timea
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 642 - 654
  • [26] Infectious and Inflammatory Diseases of the Kidney
    Hammond, Nancy A.
    Nikolaidis, Paul
    Miller, Frank H.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2012, 50 (02) : 259 - +
  • [27] Inflammasomes in cardiovascular diseases
    Garg, Nisha Jain
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2011, 1 (03): : 244 - 254
  • [28] Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
    Park, Mi Hee
    Jo, Miran
    Kim, Yu Ri
    Lee, Chong-Kil
    Hong, Jin Tae
    PHARMACOLOGY & THERAPEUTICS, 2016, 163 : 1 - 23
  • [29] Inflammasomes and diseases of the skin
    Mitra, A. D.
    Schrock, D.
    Raychaudhuri, S. P.
    Raychaudhuri, S. K.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2012, 78 (03): : 394 - 402
  • [30] Inflammasomes in human diseases
    Jamilloux, Y.
    Seve, P.
    Henry, T.
    REVUE DE MEDECINE INTERNE, 2014, 35 (11): : 730 - 741